Medicure Inc.

198 articles with Medicure Inc.

• Medicure Inc. To Announce Fiscal Year 2015 Financial Results on March 30, 2016

  3/24/2016

• Medicure Inc. Release: Meta-Analysis Of AGGRASTAT (Tirofiban HCL) Presented At CRT 2016 Conference

  2/23/2016

• Medicure Inc. To Present At Cantech Investment Conference

  1/21/2016

• Medicure Inc. Announces ANDA Collaboration With Apicore

  1/6/2016

• Medicure Inc. Announces PDUFA Action Date For New Aggrastat Indication

  12/2/2015

• Medicure Inc. Announces Grant Of Stock Options

  11/30/2015

• Medicure Inc. Reports Third Quarter 2015 Financial Results

  11/10/2015

• Medicure Inc. Reports Financial Results For The First Quarter Of 2015

  4/30/2015

• Medicure Inc. Q1 Results And Conference Call Dates

  4/24/2015

• Medicure Inc. To Present At The 2015 Bloom Burton & Co. Healthcare Conference

  4/23/2015

• Medicure Inc. Announces Approval Of Expanded Dosing Time For AGGRASTAT

  4/23/2015

• Medicure Inc. Grabs Minority Position In Pharmaceutical Manufacturer, Apicore LLC

  7/3/2014

• Medicure Inc. Announces Intention to Seek Expanded Aggrastat Label

  10/2/2012

• Medicure Inc. Announces Development of Novel Aggrastat Formulation

  9/26/2012

• Medicure Inc. Announces Appointment of Dawson Reimer as President and Chief Operating Officer

  7/25/2011

• Medicure Inc. Announces Birmingham Debt Settlement

  7/19/2011

• Medicure Inc. Announces Further Agreement With Secured Lender and Provides Update on Strategic Review Process

  7/15/2010

• Medicure Inc. Announces Further Agreement With Secured Lender

  4/12/2010

• Medicure Inc. Announces Further Agreement With Secured Lender

  4/1/2010

• Medicure Inc. Announces Transfer to NEX Board of TSX Venture Exchange

  3/29/2010